{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:54:53Z","timestamp":1790013293483,"version":"4.0.1"},"reference-count":32,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,2,24]],"date-time":"2009-02-24T00:00:00Z","timestamp":1235433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2009,5]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>\n                      <jats:bold>Background\u2002<\/jats:bold>\n                      Tetracycline derivatives provide moderate benefit in the treatment of ocular rosacea. Recently, azithromycin has been found to be an effective alternative in the treatment of cutaneous papulopustular rosacea.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>Objective\u2002<\/jats:bold>\n                      We planned a study to evaluate the effects of azithromycin on ocular symptoms, signs and tear function tests of papulopustular rosacea patients.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>Methods\u2002<\/jats:bold>\n                      An open\u2010labelled study was performed in a population of 20 papulopustular rosacea patients.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>Results\u2002<\/jats:bold>\n                      Eighteen subjects completed the trial. Significant improvement was seen in ocular symptoms, eyelid findings and conjunctival hyperaemia scores (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.002,\n                      <jats:italic>P\u00a0&lt;<\/jats:italic>\n                      \u00a00.0001, and\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.005, respectively). Therapeutic benefit was not observed in ocular surface staining scores. Baseline values of Schirmer test results were within normal limits. No significant side\u2010effects were observed.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>Limitations\u2002<\/jats:bold>\n                      The study population is limited to dermatology patients who had been referred to the ophthalmology clinic.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>Conclusion\u2002<\/jats:bold>\n                      Azithromycin may be a new promising therapeutic alternative in ocular rosacea.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conflicts of interest<\/jats:title>\n                    <jats:p>None declared.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1468-3083.2009.03132.x","type":"journal-article","created":{"date-parts":[[2009,2,24]],"date-time":"2009-02-24T05:42:44Z","timestamp":1235454164000},"page":"544-549","source":"Crossref","is-referenced-by-count":60,"title":["Ocular signs, symptoms and tear function tests of papulopustular rosacea patients receiving azithromycin"],"prefix":"10.1111","volume":"23","author":[{"given":"\u00d6","family":"Bakar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Demircay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Toker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"\u00c7ak\u0131r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,4,3]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.03.030"},{"key":"e_1_2_6_3_2","first-page":"20","article-title":"Frequency, severity and treatment of ocular rosacea during cutaneous rosacea","volume":"130","author":"Michel JL","year":"2003","journal-title":"Ann Dermatol Venereol"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1177\/003591576906200107"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120625"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-200304000-00009"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(79)90525-7"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(97)30015-3"},{"key":"e_1_2_6_9_2","first-page":"112","article-title":"The ocular manifestations of rosacea","volume":"68","author":"Tanzi EL","year":"2001","journal-title":"Cutis"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.03.033"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-200401000-00020"},{"key":"e_1_2_6_12_2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archderm.1997.03890370055009","article-title":"Ocular rosacea. Signs symptoms, and tear studies before and after treatment with doxycycline","volume":"133","author":"Quarterman MJ","year":"1997","journal-title":"Arch Dermatol"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)71750-7"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-1549(02)00106-2"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0738-081X(02)00324-3"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.01958.x"},{"key":"e_1_2_6_17_2","first-page":"209","article-title":"A comparative study of eyelid cleaning regimens in chronic blepharitis","volume":"22","author":"Key JE","year":"1996","journal-title":"CLAO J"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.icu.0000143683.14738.76"},{"key":"e_1_2_6_19_2","first-page":"109","article-title":"Effects of eyelid scrubbing on the lid margin","volume":"25","author":"Greiner JV","year":"1999","journal-title":"CLAO J"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2006.02322.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2000.00749.x"},{"issue":"9","key":"e_1_2_6_22_2","first-page":"2S","article-title":"Immunomodulatory properties of macrolides: overview and historical perspective","volume":"117","author":"Rubin BK","year":"2004","journal-title":"Am J Med"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(97)30014-1"},{"key":"e_1_2_6_24_2","first-page":"2506","article-title":"Tear fluid gelatinase B activity correlates with IL\u20101\u03b1 concentration and fluorescein clearance in ocular rosacea","volume":"40","author":"Afonso AA","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"e_1_2_6_25_2","first-page":"5S","article-title":"Clinical implications of the immunomodulatory effects of macrolides","volume":"117","author":"Tamaoki J","year":"2004","journal-title":"Am J Med"},{"issue":"2","key":"e_1_2_6_26_2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1378\/chest.125.2_suppl.41S","article-title":"The effects of macrolides on inflammatory cells","volume":"125","author":"Tamaoki J.","year":"2004","journal-title":"Chest"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.116.12.1625"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(90)32403-X"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1177\/112067210201200103"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)90170-7"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.118.12.1632"},{"key":"e_1_2_6_32_2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/112067210301300404","article-title":"Impression cytology and ocular characteristics in ocular rosacea","volume":"13","author":"Ko\u00e7ak\u2010Altynta\u015f AG","year":"2003","journal-title":"Eur J Ophthalmol"},{"key":"e_1_2_6_33_2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/112067210801800103","article-title":"Tear concentrations of azithromycin following topical administration of a single dose of azithromycin 0.5%, 1.0%, and 1.5% eyedrops (T1225) in healthy volunteers","volume":"18","author":"Chiambaretta F","year":"2008","journal-title":"Eur J Ophthalmol"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2009.03132.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2009.03132.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T18:10:51Z","timestamp":1697047851000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2009.03132.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,3]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["10.1111\/j.1468-3083.2009.03132.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03132.x","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718430987.793495896","asserted-by":"object"}]},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,3]]}}}